National Cancer Institute of Canada Recognizes Country's Leading Cancer Researchers



    10 Winners Awarded First Ever Diamond Jubilee Award

    TORONTO, Nov. 16 /CNW/ - The National Cancer Institute of Canada (NCIC),
the country's longest-standing research organization dedicated to supporting
excellent cancer research and advancing cancer control, presented the first
ever Diamond Jubilee Awards to 10 of Canada's leading cancer researchers at a
special presentation tonight.
    The Diamond Jubilee Award is a one-time award, created on the occasion of
the NCIC's 60th anniversary, to recognize researchers who have made truly
outstanding contributions to cancer research in Canada over their careers. The
dedication and landmark achievements of the award winners have led to new
insights and developments in the many facets of cancer research, leading the
way for current and future researchers to expand on their work.
    "We are here tonight to celebrate 60 outstanding years of progress in
cancer research and to honour several of the very best cancer researchers
Canada has produced," says Dr. Elizabeth Eisenhauer, President of the NCIC.
"In cancer research, every new finding builds on the one that came before it.
Over the past 60 years, researchers have uncovered a multitude of answers to
many of the most pressing cancer questions, leading to vast improvements in
prevention, early detection and treatment. The outstanding researchers we are
honouring today have laid a rock solid foundation, putting us in a position of
great strength to build on. They represent our past and also our future. For
this, we are very grateful and proud to be here in such distinguished
company."

    
    The first ever Diamond Jubilee Award winners are:

    -   Dr. Roy Cameron, Executive Director of NCIC's Centre for Behavourial
        Research and Program Evaluation (CBRPE)/University of Waterloo, for
        his work in tobacco control, cancer control, public policy and
        population health. CBRPE is funded by the Canadian Cancer Society.

    -   Dr. Anthony Pawson, Samuel Lunenfeld Research Institute/Mount Sinai
        Hospital, for his work in clarifying basic mechanisms of cancer cell
        signaling that has transformed our view of cancer biology.

    -   Dr. Victor Ling of the BC Cancer Agency/BC Cancer Research Centre;
        Dr. Roger Deeley of Queen's Cancer Research Institute/Queen's
        University; and Dr. Susan Cole of the Division of Cancer Biology &
        Genetics/Queen's University, for their paradigm-shifting discoveries
        related to better understanding of resistance to cancer treatment.

    -   Dr. James Till of the Ontario Cancer Institute/University Health
        Network; Dr. Ernest McCulloch retired from Princess Margaret
        Hospital; and Dr. John Dick of the Ontario Cancer
        Institute/University Health Network, for their seminal work in cancer
        stem cell research.

    -   Dr. Lesley Degner of the Faculty of Nursing, University of Manitoba,
        for her research into behaviours and supportive care leading to
        improved quality-of-life and supportive tools for cancer patients.

    -   Dr. Joseph Pater of the NCIC Clinical Trials Group/Queen's
        University, for his work in identifying new and effective cancer
        therapies which have improved patients' survival and lives. The NCIC
        Clinical Trials Group is funded by the Canadian Cancer Society.
    

    "Sixty years ago, when the NCIC was founded, little was known about
cancer," says Dr. Michael Wosnick, Executive Director of the NCIC. "Today, it
is a very different story, thanks to the combined efforts of our superb
Canadian research community and the continued generosity of the Canadian
public who make research possible. The progress in these years has been
nothing short of astonishing; from a survival rate of only 25 per cent in the
1940s, to 60 per cent today. We can only imagine what research will contribute
to growing this rate even higher."
    The awards were presented at a special dinner at the Toronto
Intercontinental Hotel with the University Health Network (Ontario Cancer
Institute/Princess Margaret Hospital) as awards dinner sponsor.

    From its humble beginnings in 1947 with a staff of two, the NCIC has
grown to become Canada's largest charitably funded cancer research granting
organization. To date, we have contributed more than $1.3 billion in funding
to thousands of outstanding researchers nationwide. Through committed
investment from the Canadian Cancer Society and The Terry Fox Foundation, NCIC
grants cover all facets of cancer research from basic molecular investigations
to behavioural and prevention studies.

    For more information about the NCIC, please visit www.ncic.cancer.ca.

    /NOTE TO PHOTO EDITORS: A photo accompanying this release is available on
    the CNW Photo Network and archived at http://photos.newswire.ca.
    Additional archived images are also available on the CNW Photo Archive
    website at http://photos.newswire.ca. Images are free to accredited
    members of the media/





For further information:

For further information: or to arrange an interview with one of the
winners, please contact: Diana Robinson, Diana Robinson & Associates, (416)
871-5420, (519) 829-3804, dianarobinsonassociates@rogers.com

Organization Profile

NATIONAL CANCER INSTITUTE OF CANADA INITIATIVE

More on this organization


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890